NovaBay Pharmaceuticals Shares Outstanding 2007-2019 | NBY

NovaBay Pharmaceuticals shares outstanding from 2007 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
NovaBay Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 17
2017 15
2016 9
2015 3
2014 2
2013 2
2012 1
2011 1
2010 1
2009 1
2008 1
2007 0
2006 0
2005 0
NovaBay Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 17
Q4 2018 17
Q3 2018 17
Q2 2018 17
Q1 2018 17
Q4 2017 15
Q3 2017 15
Q2 2017 15
Q1 2017 15
Q4 2016 9
Q3 2016 11
Q2 2016 7
Q1 2016 4
Q4 2015 3
Q3 2015 3
Q2 2015 3
Q1 2015 2
Q4 2014 2
Q3 2014 2
Q2 2014 2
Q1 2014 2
Q4 2013 2
Q3 2013 1
Q2 2013 1
Q1 2013 1
Q4 2012 1
Q3 2012 1
Q2 2012 1
Q1 2012 1
Q4 2011 1
Q3 2011 1
Q2 2011 1
Q1 2011 1
Q4 2010 1
Q3 2010 1
Q2 2010 1
Q1 2010 1
Q4 2009 1
Q3 2009 1
Q2 2009 1
Q1 2009 1
Q4 2008 1
Q3 2008 1
Q2 2008 1
Q1 2008 1
Q4 2007 0
Q3 2007 0
Q2 2007 0
Q1 2007 0
Q3 2006 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.032B $0.013B
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $53.030B 33.88
Takeda Pharmaceutical (TAK) Japan $26.701B 7.84
Grifols (GRFS) Spain $13.249B 16.76
Sage Therapeutics (SAGE) United States $8.913B 0.00
Ionis Pharmaceuticals (IONS) United States $8.713B 19.05
Neurocrine Biosciences (NBIX) United States $7.661B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.390B 10.13
Catalent (CTLT) United States $7.241B 29.06
Nektar Therapeutics (NKTR) United States $5.822B 9.49
Tilray (TLRY) Canada $3.793B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.518B 12.34
FibroGen (FGEN) United States $3.505B 0.00
United Therapeutics (UTHR) United States $3.427B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.448B 368.86
PTC Therapeutics (PTCT) United States $2.338B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.052B 7.39
Pacira Pharmaceuticals (PCRX) United States $1.803B 87.32
Xencor (XNCR) United States $1.764B 48.17
Portola Pharmaceuticals (PTLA) United States $1.754B 0.00
USANA Health Sciences (USNA) United States $1.738B 15.10
Tricida (TCDA) United States $1.694B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.688B 23.07
Zogenix (ZGNX) United States $1.661B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.604B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.504B 0.00
Aerie Pharmaceuticals (AERI) United States $1.457B 0.00
Heron Therapeutics (HRTX) United States $1.398B 0.00
Esperion Therapeutics (ESPR) United States $1.324B 0.00
Turning Point Therapeutics (TPTX) United States $1.245B 0.00
Corcept Therapeutics (CORT) United States $1.190B 16.98
Radius Health (RDUS) United States $1.014B 0.00
Endo (ENDP) Ireland $0.916B 1.47
ArQule (ARQL) United States $0.896B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.895B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.834B 0.00
CannTrust Holdings (CTST) Canada $0.683B 0.00
Organogenesis Holdings (ORGO) United States $0.669B 0.00
Odonate Therapeutics (ODT) United States $0.669B 0.00
Aptorum Group (APM) China $0.649B 0.00
TherapeuticsMD (TXMD) United States $0.589B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.562B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.521B 0.00
Translate Bio (TBIO) United States $0.511B 0.00
Dermira (DERM) United States $0.506B 0.00
ChemoCentryx (CCXI) United States $0.484B 0.00
Akebia Therapeutics (AKBA) United States $0.483B 0.00
GlycoMimetics (GLYC) United States $0.483B 0.00
Siga Technologies (SIGA) United States $0.443B 1.04
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Flexion Therapeutics (FLXN) United States $0.414B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.409B 20.65
Collegium Pharmaceutical (COLL) United States $0.402B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.391B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.374B 0.00
Karyopharm Therapeutics (KPTI) United States $0.348B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.344B 0.00
KalVista Pharmaceuticals (KALV) United States $0.343B 0.00
Forty Seven (FTSV) United States $0.331B 0.00
TCR2 Therapeutics (TCRR) United States $0.327B 0.00
CASI Pharmaceuticals (CASI) United States $0.301B 0.00
ImmunoGen (IMGN) United States $0.296B 0.00
Harpoon Therapeutics (HARP) United States $0.290B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.285B 0.00
OptiNose (OPTN) United States $0.285B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.263B 0.00
Molecular Templates (MTEM) United States $0.262B 0.00
Dova Pharmaceuticals (DOVA) United States $0.261B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
Concert Pharmaceuticals (CNCE) United States $0.256B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.240B 0.00
Aratana Therapeutics (PETX) United States $0.234B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.225B 0.00
Lannett Co Inc (LCI) United States $0.205B 1.99
Calithera Biosciences (CALA) United States $0.204B 0.00
Recro Pharma (REPH) United States $0.201B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.193B 0.00
Ocular Therapeutix (OCUL) United States $0.187B 0.00
IMV INC (IMV) Canada $0.187B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.186B 0.00
Aldeyra Therapeutics (ALDX) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 57.31
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.175B 0.00
MEI Pharma (MEIP) United States $0.175B 0.00
Minerva Neurosciences (NERV) United States $0.172B 0.00
Galectin Therapeutics (GALT) United States $0.168B 0.00
Ardelyx (ARDX) United States $0.167B 0.00
Opexa Therapeutics (ACER) United States $0.166B 0.00
Bio Blast Pharma (ENLV) Israel $0.164B 0.00
Redhill Biopharma (RDHL) Israel $0.158B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.146B 0.00
Jounce Therapeutics (JNCE) United States $0.146B 0.00
Majesco Entertainment (PTE) United States $0.144B 0.00
Neon Therapeutics (NTGN) United States $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.129B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.119B 0.00
Tyme Technologies (TYME) United States $0.116B 0.00
Aquestive Therapeutics (AQST) United States $0.105B 0.00
Iterum Therapeutics (ITRM) Ireland $0.103B 0.00
MediWound (MDWD) Israel $0.102B 0.00
Champions Oncology (CSBR) United States $0.101B 0.00
Avenue Therapeutics (ATXI) United States $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.097B 69.44
Natural Alternatives (NAII) United States $0.092B 9.15
Infinity Pharmaceuticals (INFI) United States $0.091B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.089B 0.00
Mast Therapeutics (SVRA) United States $0.088B 0.00
Cardiome Pharma (CORV) Canada $0.088B 0.00
Capnia (SLNO) United States $0.087B 0.00
DURECT (DRRX) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Nivalis Therapeutics (ALPN) United States $0.080B 0.00
Adherex Technologies (FENC) United States $0.080B 0.00
Otonomy (OTIC) United States $0.078B 0.00
Genocea Biosciences (GNCA) United States $0.074B 0.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Novan (NOVN) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
ElectroCore (ECOR) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Zafgen (ZFGN) United States $0.051B 0.00
ProNAi Therapeutics (SRRA) Canada $0.049B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
KemPharm (KMPH) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Bio-Path Holdings (BPTH) United States $0.040B 0.00
Lipocine (LPCN) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.038B 0.00
ContraFect (CFRX) United States $0.037B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.037B 0.00
PharmAthene (ALT) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
Pain Therapeutics (SAVA) United States $0.021B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Melinta Therapeutics (MLNT) United States $0.020B 0.00
PRECISION THERAPEUTICS INC (POAI) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 1.38
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.82
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00